| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | CEO Of Specialty Renal Product | President And CEO
2 companies
Evans Daron is a CFO at Rezolute, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 14 buys and 0 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | RZLT Rezolute, Inc. | CFO | Buy | 45,000 | $1.77 | $79,577.50 | +11.7% | +52.8% | - | |
| Dec 9, 2025 | RZLT Rezolute, Inc. | CFO | Buy | 10,549 | $5.04 | $53,166.96 | +8.7% | -67.0% | - | |
| Jun 24, 2025 | RZLT Rezolute, Inc. | CFO | Buy | 5,000 | $4.05 | $20,250.00 | +1.9% | +92.0% | - | |
| Mar 26, 2025 | RZLT Rezolute, Inc. | CFO | Buy | 20,000 | $2.89 | $57,700.00 | +8.3% | +55.3% | +19.0% | |
| Dec 18, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 10,000 | $4.29 | $42,900.00 | +7.1% | -17.4% | -54.7% | |
| Dec 12, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 9,000 | $4.60 | $41,400.00 | +6.8% | -19.0% | -61.2% | |
| Jun 14, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 40,000 | $4.04 | $161,568.00 | New | +32.2% | +6.3% | |
| May 29, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 451 | $3.50 | $1,578.50 | +0.4% | +16.0% | +0.6% | |
| May 24, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 3,000 | $3.22 | $9,667.96 | +15.0% | +19.4% | +9.3% | |
| Mar 15, 2024 | RZLT Rezolute, Inc. | CFO | Buy | 20,000 | $1.69 | $33,830.00 | New | +189.9% | +102.2% |